• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Neoadjuvant therapy for resectable pancreatic cancers.可切除胰腺癌的新辅助治疗
Hepatobiliary Surg Nutr. 2022 Aug;11(4):583-585. doi: 10.21037/hbsn-22-31.
2
Neoadjuvant therapy for pancreatic cancer.胰腺癌的新辅助治疗。
Updates Surg. 2022 Feb;74(1):35-42. doi: 10.1007/s13304-021-01186-1. Epub 2021 Oct 9.
3
Contemporary trials evaluating neoadjuvant therapy for resectable pancreatic cancer.当代评估可切除胰腺癌新辅助治疗的临床试验。
J Surg Oncol. 2021 May;123(6):1423-1431. doi: 10.1002/jso.26393.
4
How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers.新辅助治疗后如何处理胰腺癌：多排 CT 和肿瘤标志物评估可切除性。
Eur Radiol. 2022 Jan;32(1):56-66. doi: 10.1007/s00330-021-08108-0. Epub 2021 Jun 25.
5
Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma.可切除及边界可切除胰腺腺癌新辅助放化疗联合或不联合全身化疗的疗效
Front Oncol. 2020 Sep 16;10:1461. doi: 10.3389/fonc.2020.01461. eCollection 2020.
6
Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials.可切除和交界可切除胰腺癌的新辅助治疗或 upfront 手术：随机对照试验的荟萃分析。
Eur J Cancer. 2022 Jan;160:140-149. doi: 10.1016/j.ejca.2021.10.023. Epub 2021 Nov 24.
7
Tumor resectability and response on CT following neoadjuvant therapy for pancreatic cancer: inter-observer agreement study.新辅助治疗后胰腺癌的肿瘤可切除性和 CT 反应：观察者间一致性研究。
Eur Radiol. 2022 Jun;32(6):3799-3807. doi: 10.1007/s00330-021-08494-5. Epub 2022 Jan 15.
8
Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation.可切除胰腺癌的新辅助治疗与辅助治疗：放疗的作用演变
Semin Radiat Oncol. 2014 Apr;24(2):113-25. doi: 10.1016/j.semradonc.2013.11.002.
9
Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy.可切除边缘性胰腺癌及新辅助放化疗的作用
Updates Surg. 2016 Sep;68(3):235-239. doi: 10.1007/s13304-016-0392-x. Epub 2016 Sep 15.
10
Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer.新辅助治疗与边界可切除胰腺癌患者生存改善相关。
Ann Surg Oncol. 2020 Apr;27(4):1191-1200. doi: 10.1245/s10434-019-08087-z. Epub 2019 Dec 4.

引用本文的文献

1
Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis.基于综合多组学分析鉴定胰腺导管腺癌的候选药物
J Gastrointest Oncol. 2024 Jun 30;15(3):1265-1281. doi: 10.21037/jgo-23-985. Epub 2024 Jun 27.

本文引用的文献

1
Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials.可切除胰腺癌的新辅助治疗：一种新的护理标准。来自3项随机对照试验的汇总数据。
Ann Surg. 2021 Nov 1;274(5):713-720. doi: 10.1097/SLA.0000000000005126.
2
High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment.在可切除的胰腺癌中，CA19-9 水平升高是新辅助治疗的一个潜在指征。
Pancreatology. 2021 Jan;21(1):130-137. doi: 10.1016/j.pan.2020.11.026. Epub 2020 Dec 4.
3
Neoadjuvant gemcitabine and nab-paclitaxel for borderline resectable pancreatic cancers: Intention-to-treat analysis compared with upfront surgery.吉西他滨联合 nab-紫杉醇新辅助治疗局部进展期可切除胰腺癌：与直接手术比较的意向治疗分析。
J Hepatobiliary Pancreat Sci. 2021 Feb;28(2):143-155. doi: 10.1002/jhbp.844. Epub 2020 Nov 11.
4
Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection?影像学隐匿性转移性胰腺癌：如何避免无益性切除术？
Langenbecks Arch Surg. 2020 Feb;405(1):35-41. doi: 10.1007/s00423-019-01846-2. Epub 2019 Nov 28.
5
A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.一项新辅助吉西他滨和 S1 治疗可切除和交界可切除胰腺腺癌患者的单臂、二期临床试验：PREP-01 研究。
J Gastroenterol. 2019 Feb;54(2):194-203. doi: 10.1007/s00535-018-1506-7. Epub 2018 Sep 4.
6
Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets.新辅助放化疗与单纯手术治疗可切除胰腺癌的比较：一项未达到入组目标的单中心前瞻性随机对照试验
J Gastrointest Surg. 2015 Oct;19(10):1802-12. doi: 10.1007/s11605-015-2890-4. Epub 2015 Jul 30.
7
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial.吉西他滨/顺铂新辅助放化疗联合手术与直接手术治疗可切除胰腺癌的比较：首个前瞻性随机II期试验结果
Strahlenther Onkol. 2015 Jan;191(1):7-16. doi: 10.1007/s00066-014-0737-7. Epub 2014 Sep 25.
8
Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).交界可切除胰腺癌：国际胰腺外科研究组（ISGPS）的共识声明。
Surgery. 2014 Jun;155(6):977-88. doi: 10.1016/j.surg.2014.02.001. Epub 2014 Feb 7.
9
Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.辅助手术对初始不可切除的胰腺癌患者的作用：这些患者对非手术抗癌治疗有长期良好反应，日本肝胆胰外科学会胰腺手术项目研究结果
J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):590-600. doi: 10.1007/s00534-013-0616-0.
10
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).可切除胰腺癌中辅助吉西他滨与新辅助吉西他滨/奥沙利铂加辅助吉西他滨的比较：一项随机多中心 III 期研究（NEOPAC 研究）。
BMC Cancer. 2011 Aug 10;11:346. doi: 10.1186/1471-2407-11-346.

Neoadjuvant therapy for resectable pancreatic cancers.

作者信息

Inoue Yosuke, Ito Hiromichi, Takahashi Yu

机构信息

Division of Hepato-Biliary-Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

出版信息

Hepatobiliary Surg Nutr. 2022 Aug;11(4):583-585. doi: 10.21037/hbsn-22-31.

DOI:10.21037/hbsn-22-31
PMID:36016746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9396094/
Abstract
摘要